Related Experiment Video

Updated: May 31, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.3K

The Expression Regulation and Cancer-Promoting Roles of RACGAP1

Jiacheng Lin1,2, Yuhao Zhu1,2, Zhaoping Lin1,2

  • 1Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, China.

Biomolecules
|January 25, 2025
PubMed

Insights

RACGAP1, a Rho-GTPase-activating protein, traditionally a tumor suppressor, paradoxically promotes cancer by activating Rho GTPases and mediating oncogene expression. Its dual role and impact on drug sensitivity require further investigation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • RACGAP1 (Rho GTPase-activating protein 1) is initially identified in male germ cells.
  • Traditionally recognized as a tumor suppressor, its role in cancer is increasingly complex.
  • RACGAP1's function involves regulating Rho GTPases like Rac and RhoA.

Purpose of the Study:

  • To review the expression regulation of RACGAP1.
  • To elucidate RACGAP1's cancer-promoting functions.
  • To analyze its role in oncogene expression and Rho-GTPase activation.

Main Methods:

  • Literature review of existing studies on RACGAP1.
  • Analysis of RACGAP1's involvement in cancer signaling pathways.
  • Examination of RACGAP1's impact on gene expression and cell division.

Main Results:

  • Overexpressed RACGAP1 can activate Rac and RhoA in various cancers, contrasting with its tumor-suppressive role.
  • RACGAP1 aids nuclear translocation of signaling molecules and regulates cytoskeleton for cytokinesis.
  • Contradictory findings exist, with RACGAP1 reported to inactivate Rac and RhoA in gastric cancer.
  • RACGAP1 serves as a prognostic biomarker and affects doxorubicin sensitivity.

Conclusions:

  • RACGAP1 exhibits context-dependent roles in cancer, acting as both a suppressor and promoter.
  • Its dysregulation contributes to oncogenesis through altered Rho-GTPase signaling and gene expression.
  • Understanding RACGAP1's complex functions is crucial for developing targeted cancer therapies.
Keywords:
ECT2RACGAP1Rho-GTPasesSTAT3

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.4K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

10.8K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K